The most characteristic observation in this regard is the IFN signature in SLE patients with increased levels of type I IFNs, especially IFNα [42], which is actually known to reduce the T-cell response during chronic infections and inflammation [43]. The gene discussed is IFNA1; the disease is systemic lupus erythematosus.